 Akira Miyake
Concepts (818)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Individuality | 20 | 2023 | 157 | 3.510 |
Why?
| | Executive Function | 13 | 2019 | 431 | 2.210 |
Why?
| | Memory, Short-Term | 11 | 2021 | 263 | 1.840 |
Why?
| | Cognition | 17 | 2023 | 1122 | 1.630 |
Why?
| | Attention | 15 | 2023 | 438 | 1.510 |
Why?
| | Reading | 8 | 2024 | 150 | 1.500 |
Why?
| | Evoked Potentials | 3 | 2024 | 116 | 1.370 |
Why?
| | Aptitude | 6 | 2017 | 38 | 1.170 |
Why?
| | Self-Control | 3 | 2023 | 55 | 1.090 |
Why?
| | Electroencephalography | 3 | 2024 | 403 | 0.960 |
Why?
| | Ego | 3 | 2023 | 11 | 0.910 |
Why?
| | Memory | 8 | 2016 | 255 | 0.840 |
Why?
| | Comprehension | 3 | 2024 | 165 | 0.780 |
Why?
| | Self Concept | 2 | 2016 | 242 | 0.750 |
Why?
| | Reaction Time | 10 | 2018 | 410 | 0.690 |
Why?
| | Universities | 2 | 2021 | 408 | 0.670 |
Why?
| | Psychomotor Performance | 6 | 2018 | 313 | 0.670 |
Why?
| | Pessimism | 1 | 2019 | 6 | 0.630 |
Why?
| | Anxiety | 2 | 2016 | 965 | 0.610 |
Why?
| | Internal-External Control | 2 | 2016 | 69 | 0.610 |
Why?
| | Task Performance and Analysis | 3 | 2016 | 173 | 0.610 |
Why?
| | Psycholinguistics | 2 | 2017 | 20 | 0.570 |
Why?
| | Language | 4 | 2024 | 283 | 0.520 |
Why?
| | Mental Recall | 7 | 2008 | 192 | 0.520 |
Why?
| | Students | 3 | 2022 | 580 | 0.510 |
Why?
| | Orientation | 3 | 2002 | 44 | 0.490 |
Why?
| | Neuropsychological Tests | 14 | 2017 | 1015 | 0.480 |
Why?
| | Epidermal Growth Factor | 5 | 1998 | 171 | 0.480 |
Why?
| | Humans | 107 | 2024 | 129622 | 0.450 |
Why?
| | Cooperative Behavior | 2 | 2016 | 431 | 0.450 |
Why?
| | Cerebral Cortex | 3 | 2017 | 437 | 0.450 |
Why?
| | Female | 76 | 2024 | 68770 | 0.420 |
Why?
| | Space Perception | 4 | 2016 | 78 | 0.420 |
Why?
| | Verbal Behavior | 2 | 2004 | 46 | 0.410 |
Why?
| | Learning | 2 | 2022 | 402 | 0.400 |
Why?
| | Interpersonal Relations | 1 | 2016 | 392 | 0.400 |
Why?
| | Racism | 1 | 2015 | 129 | 0.400 |
Why?
| | Brain | 5 | 2024 | 2679 | 0.390 |
Why?
| | Cognition Disorders | 4 | 2023 | 504 | 0.390 |
Why?
| | Young Adult | 17 | 2024 | 12426 | 0.380 |
Why?
| | Male | 56 | 2024 | 63674 | 0.380 |
Why?
| | Ether-A-Go-Go Potassium Channels | 2 | 2009 | 4 | 0.380 |
Why?
| | Physics | 1 | 2010 | 17 | 0.350 |
Why?
| | Social Values | 1 | 2010 | 34 | 0.350 |
Why?
| | Cues | 4 | 2016 | 326 | 0.350 |
Why?
| | Achievement | 1 | 2010 | 57 | 0.340 |
Why?
| | Frontal Lobe | 3 | 2008 | 154 | 0.330 |
Why?
| | Chromans | 3 | 1994 | 24 | 0.320 |
Why?
| | Adult | 38 | 2024 | 35572 | 0.320 |
Why?
| | Verbal Learning | 2 | 2002 | 67 | 0.320 |
Why?
| | Heart Defects, Congenital | 4 | 2022 | 758 | 0.320 |
Why?
| | Pattern Recognition, Visual | 3 | 2015 | 98 | 0.310 |
Why?
| | Phospholipases A | 3 | 1994 | 99 | 0.310 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2009 | 182 | 0.310 |
Why?
| | Receptors, Cholecystokinin | 4 | 1997 | 5 | 0.300 |
Why?
| | Adolescent | 28 | 2024 | 20391 | 0.300 |
Why?
| | Models, Psychological | 4 | 2016 | 307 | 0.290 |
Why?
| | Goals | 3 | 2015 | 160 | 0.290 |
Why?
| | Problem Solving | 3 | 2008 | 155 | 0.290 |
Why?
| | Potassium Channels | 4 | 2003 | 149 | 0.270 |
Why?
| | Prolactin | 7 | 2000 | 98 | 0.270 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 3 | 2023 | 398 | 0.270 |
Why?
| | Transforming Growth Factor alpha | 3 | 1996 | 55 | 0.270 |
Why?
| | ErbB Receptors | 5 | 1996 | 607 | 0.260 |
Why?
| | Thinking | 2 | 2021 | 58 | 0.260 |
Why?
| | Pyridazines | 2 | 1997 | 54 | 0.260 |
Why?
| | Visual Perception | 4 | 2002 | 163 | 0.260 |
Why?
| | Gene-Environment Interaction | 3 | 2017 | 185 | 0.260 |
Why?
| | Music | 1 | 2006 | 39 | 0.250 |
Why?
| | Decidua | 3 | 1997 | 23 | 0.250 |
Why?
| | Receptors, Serotonin | 4 | 2000 | 33 | 0.240 |
Why?
| | Fallopian Tubes | 3 | 1999 | 31 | 0.240 |
Why?
| | Molecular Sequence Data | 15 | 2008 | 2832 | 0.240 |
Why?
| | Hypoplastic Left Heart Syndrome | 2 | 2018 | 117 | 0.240 |
Why?
| | Receptors, Interleukin | 2 | 1995 | 43 | 0.240 |
Why?
| | Psychological Theory | 2 | 2016 | 99 | 0.230 |
Why?
| | Growth Substances | 4 | 1998 | 152 | 0.230 |
Why?
| | Pituitary Gland | 5 | 1997 | 148 | 0.230 |
Why?
| | Talc | 1 | 2024 | 7 | 0.230 |
Why?
| | Research Design | 4 | 2021 | 1043 | 0.220 |
Why?
| | Powders | 1 | 2024 | 43 | 0.220 |
Why?
| | Semantics | 2 | 2024 | 100 | 0.220 |
Why?
| | Twins, Dizygotic | 4 | 2017 | 181 | 0.220 |
Why?
| | Gene Expression | 7 | 2000 | 1472 | 0.220 |
Why?
| | RNA, Messenger | 15 | 2000 | 2708 | 0.220 |
Why?
| | Insecticides | 1 | 2024 | 33 | 0.220 |
Why?
| | Twins, Monozygotic | 4 | 2017 | 210 | 0.220 |
Why?
| | Adolescent Development | 2 | 2016 | 84 | 0.210 |
Why?
| | Potassium Channels, Voltage-Gated | 2 | 2002 | 50 | 0.210 |
Why?
| | Phenols | 2 | 1994 | 97 | 0.200 |
Why?
| | Anti-Asthmatic Agents | 2 | 1997 | 374 | 0.200 |
Why?
| | Nerve Tissue Proteins | 3 | 2008 | 570 | 0.200 |
Why?
| | Long QT Syndrome | 2 | 2014 | 67 | 0.200 |
Why?
| | Pseudohypoparathyroidism | 1 | 2001 | 3 | 0.190 |
Why?
| | Laryngismus | 1 | 2001 | 6 | 0.190 |
Why?
| | Field Dependence-Independence | 1 | 2001 | 4 | 0.190 |
Why?
| | Ovarian Neoplasms | 4 | 1999 | 490 | 0.190 |
Why?
| | Animals | 49 | 2009 | 35360 | 0.190 |
Why?
| | Blood Alcohol Content | 1 | 2021 | 5 | 0.180 |
Why?
| | Blotting, Northern | 8 | 1998 | 200 | 0.180 |
Why?
| | Reproducibility of Results | 4 | 2016 | 3083 | 0.180 |
Why?
| | Japan | 6 | 2024 | 98 | 0.180 |
Why?
| | Saccades | 2 | 2015 | 39 | 0.170 |
Why?
| | Chemotactic Factors | 2 | 1997 | 54 | 0.170 |
Why?
| | Enzyme Inhibitors | 3 | 2010 | 827 | 0.170 |
Why?
| | Cell Line | 11 | 2003 | 2781 | 0.170 |
Why?
| | Chemokines, CXC | 2 | 1997 | 70 | 0.170 |
Why?
| | Telencephalon | 1 | 1999 | 15 | 0.160 |
Why?
| | 8-Bromo Cyclic Adenosine Monophosphate | 2 | 1996 | 20 | 0.160 |
Why?
| | Amino Acid Sequence | 11 | 2008 | 2058 | 0.160 |
Why?
| | Polymerase Chain Reaction | 8 | 2001 | 1038 | 0.160 |
Why?
| | Interleukin-6 | 4 | 1997 | 720 | 0.160 |
Why?
| | Surveys and Questionnaires | 5 | 2019 | 5401 | 0.160 |
Why?
| | Scimitar Syndrome | 1 | 2018 | 9 | 0.150 |
Why?
| | Heterotaxy Syndrome | 1 | 2018 | 10 | 0.150 |
Why?
| | Hypothalamus | 2 | 1996 | 149 | 0.150 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 1997 | 375 | 0.150 |
Why?
| | Cardiovascular Surgical Procedures | 1 | 2018 | 28 | 0.150 |
Why?
| | Rats | 18 | 2000 | 5499 | 0.150 |
Why?
| | Emotions | 1 | 2023 | 538 | 0.150 |
Why?
| | Twins | 4 | 2014 | 249 | 0.140 |
Why?
| | Mice | 19 | 2009 | 16937 | 0.140 |
Why?
| | Guidelines as Topic | 1 | 2000 | 264 | 0.140 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 4 | 1999 | 181 | 0.140 |
Why?
| | Menstrual Cycle | 2 | 1995 | 121 | 0.140 |
Why?
| | Child Development | 2 | 2012 | 457 | 0.140 |
Why?
| | Cystadenocarcinoma | 1 | 1996 | 2 | 0.130 |
Why?
| | Follicle Stimulating Hormone | 8 | 1997 | 236 | 0.130 |
Why?
| | CA-125 Antigen | 1 | 1996 | 15 | 0.130 |
Why?
| | Estradiol | 4 | 1996 | 494 | 0.130 |
Why?
| | Fibroblast Growth Factors | 1 | 1998 | 170 | 0.130 |
Why?
| | Tetradecanoylphorbol Acetate | 2 | 1993 | 149 | 0.130 |
Why?
| | Arteriovenous Malformations | 1 | 1996 | 27 | 0.130 |
Why?
| | Monosaccharide Transport Proteins | 1 | 1996 | 49 | 0.130 |
Why?
| | Intelligence | 5 | 2011 | 130 | 0.130 |
Why?
| | Mice, Inbred ICR | 5 | 1997 | 110 | 0.130 |
Why?
| | Calcium | 7 | 2001 | 1213 | 0.130 |
Why?
| | Educational Measurement | 2 | 2010 | 262 | 0.130 |
Why?
| | Alcoholic Intoxication | 1 | 2016 | 63 | 0.130 |
Why?
| | Random Allocation | 3 | 2018 | 346 | 0.130 |
Why?
| | Motion Pictures | 1 | 2016 | 18 | 0.130 |
Why?
| | Thromboxane-A Synthase | 1 | 1995 | 3 | 0.130 |
Why?
| | Genetic Phenomena | 1 | 2015 | 8 | 0.120 |
Why?
| | Cloning, Molecular | 6 | 2003 | 524 | 0.120 |
Why?
| | Sample Size | 1 | 2016 | 116 | 0.120 |
Why?
| | Base Sequence | 6 | 2001 | 2142 | 0.120 |
Why?
| | Association | 1 | 2015 | 12 | 0.120 |
Why?
| | Dangerous Behavior | 1 | 2015 | 20 | 0.120 |
Why?
| | Adipose Tissue | 2 | 1997 | 592 | 0.120 |
Why?
| | Cephalosporins | 2 | 1991 | 40 | 0.120 |
Why?
| | Genotype | 2 | 2011 | 1839 | 0.120 |
Why?
| | Vagina | 1 | 1996 | 175 | 0.120 |
Why?
| | Arousal | 1 | 2015 | 150 | 0.110 |
Why?
| | Dextrocardia | 1 | 2014 | 3 | 0.110 |
Why?
| | 3T3 Cells | 1 | 1994 | 153 | 0.110 |
Why?
| | Substance-Related Disorders | 2 | 2017 | 1022 | 0.110 |
Why?
| | Pregnancy, Animal | 1 | 1994 | 53 | 0.110 |
Why?
| | NAV1.5 Voltage-Gated Sodium Channel | 1 | 2014 | 12 | 0.110 |
Why?
| | Psychological Tests | 2 | 2008 | 133 | 0.110 |
Why?
| | Phonetics | 2 | 2006 | 46 | 0.110 |
Why?
| | Transplantation, Heterologous | 1 | 1994 | 192 | 0.110 |
Why?
| | Neoplasm Transplantation | 1 | 1994 | 257 | 0.110 |
Why?
| | Alternative Splicing | 2 | 2000 | 218 | 0.110 |
Why?
| | Genitalia, Female | 1 | 2014 | 38 | 0.110 |
Why?
| | Depression | 2 | 2015 | 1307 | 0.110 |
Why?
| | Stents | 1 | 2018 | 504 | 0.110 |
Why?
| | Electrocardiography | 2 | 2014 | 608 | 0.110 |
Why?
| | Saliva | 1 | 1995 | 209 | 0.110 |
Why?
| | In Vitro Techniques | 4 | 1997 | 1085 | 0.110 |
Why?
| | Carrageenan | 1 | 1993 | 8 | 0.110 |
Why?
| | Peptides | 2 | 1996 | 925 | 0.110 |
Why?
| | Macrophages, Peritoneal | 1 | 1994 | 91 | 0.110 |
Why?
| | Exons | 1 | 1995 | 342 | 0.110 |
Why?
| | Tumor Cells, Cultured | 9 | 2000 | 940 | 0.110 |
Why?
| | Recombinant Proteins | 5 | 1999 | 1304 | 0.110 |
Why?
| | Ethanol | 1 | 2018 | 589 | 0.110 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 2 | 1993 | 339 | 0.110 |
Why?
| | Dinoprostone | 1 | 1994 | 186 | 0.100 |
Why?
| | Pituitary Gland, Anterior | 5 | 1996 | 39 | 0.100 |
Why?
| | Uterus | 4 | 1999 | 207 | 0.100 |
Why?
| | Wolff-Parkinson-White Syndrome | 1 | 2013 | 19 | 0.100 |
Why?
| | Adipocytes | 1 | 1994 | 205 | 0.100 |
Why?
| | Motivation | 2 | 2014 | 546 | 0.100 |
Why?
| | Phenotype | 5 | 2017 | 3076 | 0.100 |
Why?
| | Data Collection | 1 | 2016 | 650 | 0.100 |
Why?
| | Impulsive Behavior | 1 | 2014 | 128 | 0.100 |
Why?
| | Dose-Response Relationship, Drug | 8 | 2000 | 2012 | 0.100 |
Why?
| | Ventricular Fibrillation | 1 | 2013 | 57 | 0.100 |
Why?
| | Sequence Homology, Amino Acid | 6 | 2002 | 372 | 0.100 |
Why?
| | Sincalide | 4 | 1997 | 5 | 0.100 |
Why?
| | Electrodes, Implanted | 1 | 2013 | 107 | 0.100 |
Why?
| | Magnetic Resonance Imaging | 4 | 2008 | 3408 | 0.100 |
Why?
| | Tissue Distribution | 5 | 2003 | 315 | 0.100 |
Why?
| | Immunohistochemistry | 5 | 1997 | 1698 | 0.100 |
Why?
| | Equol | 1 | 2012 | 5 | 0.100 |
Why?
| | Phytoestrogens | 1 | 2012 | 17 | 0.100 |
Why?
| | Skin Aging | 1 | 2012 | 19 | 0.100 |
Why?
| | In Situ Hybridization | 5 | 2001 | 295 | 0.100 |
Why?
| | Cells, Cultured | 10 | 2001 | 4083 | 0.100 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 1997 | 1198 | 0.090 |
Why?
| | Biomarkers, Tumor | 2 | 1996 | 1181 | 0.090 |
Why?
| | Rats, Wistar | 8 | 1997 | 441 | 0.090 |
Why?
| | Transfection | 4 | 2003 | 911 | 0.090 |
Why?
| | Alcohol Drinking | 1 | 2018 | 764 | 0.090 |
Why?
| | Binding, Competitive | 4 | 2000 | 206 | 0.090 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2014 | 203 | 0.090 |
Why?
| | DNA, Complementary | 5 | 2001 | 270 | 0.090 |
Why?
| | Longitudinal Studies | 6 | 2017 | 2716 | 0.090 |
Why?
| | Factor Analysis, Statistical | 3 | 2011 | 284 | 0.090 |
Why?
| | Glucose | 1 | 1996 | 1003 | 0.090 |
Why?
| | Hyponatremia | 1 | 2011 | 40 | 0.090 |
Why?
| | Placenta | 2 | 1997 | 723 | 0.090 |
Why?
| | Reversal Learning | 1 | 2010 | 10 | 0.090 |
Why?
| | Stereotyping | 1 | 2010 | 46 | 0.090 |
Why?
| | Temperament | 1 | 2010 | 47 | 0.080 |
Why?
| | Pituitary Function Tests | 1 | 1989 | 3 | 0.080 |
Why?
| | Sodium | 1 | 2011 | 206 | 0.080 |
Why?
| | Beclin-1 | 1 | 2009 | 11 | 0.080 |
Why?
| | Pregnancy | 11 | 2022 | 6402 | 0.080 |
Why?
| | Autonomic Nervous System | 1 | 2010 | 75 | 0.080 |
Why?
| | Postmenopause | 1 | 2012 | 351 | 0.080 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2010 | 80 | 0.080 |
Why?
| | Bayes Theorem | 2 | 2022 | 375 | 0.080 |
Why?
| | Social Environment | 2 | 2009 | 292 | 0.080 |
Why?
| | Defibrillators, Implantable | 1 | 2013 | 299 | 0.080 |
Why?
| | Ion Channel Gating | 3 | 2002 | 94 | 0.080 |
Why?
| | Maze Learning | 1 | 2009 | 104 | 0.080 |
Why?
| | Mice, Inbred DBA | 1 | 2009 | 188 | 0.080 |
Why?
| | Phospholipases A2 | 3 | 1994 | 79 | 0.080 |
Why?
| | Drug Design | 1 | 2010 | 156 | 0.080 |
Why?
| | Patch-Clamp Techniques | 5 | 2003 | 279 | 0.080 |
Why?
| | Models, Neurological | 1 | 2011 | 242 | 0.080 |
Why?
| | Fontan Procedure | 1 | 2011 | 173 | 0.080 |
Why?
| | Motor Skills | 1 | 2009 | 92 | 0.080 |
Why?
| | Epilepsy | 1 | 2013 | 329 | 0.080 |
Why?
| | Gene Expression Regulation | 2 | 1995 | 2548 | 0.080 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 1994 | 1356 | 0.080 |
Why?
| | Heart Failure | 1 | 2022 | 2149 | 0.080 |
Why?
| | Atrial Fibrillation | 1 | 2013 | 376 | 0.070 |
Why?
| | Time Factors | 9 | 2011 | 6556 | 0.070 |
Why?
| | Gonadotropin-Releasing Hormone | 6 | 1997 | 207 | 0.070 |
Why?
| | Psoriasis | 1 | 2009 | 87 | 0.070 |
Why?
| | Blastocyst | 2 | 2001 | 47 | 0.070 |
Why?
| | Speech Perception | 2 | 2002 | 83 | 0.070 |
Why?
| | Amyloid beta-Peptides | 1 | 2010 | 213 | 0.070 |
Why?
| | Age Factors | 5 | 2016 | 3144 | 0.070 |
Why?
| | Growth Inhibitors | 2 | 1997 | 44 | 0.070 |
Why?
| | Diagnosis, Differential | 4 | 2013 | 1434 | 0.070 |
Why?
| | Infant, Newborn | 4 | 2022 | 5762 | 0.070 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2009 | 254 | 0.070 |
Why?
| | Analysis of Variance | 2 | 2004 | 1288 | 0.070 |
Why?
| | Natriuretic Peptide, Brain | 2 | 2022 | 99 | 0.070 |
Why?
| | Paraventricular Hypothalamic Nucleus | 2 | 1997 | 27 | 0.070 |
Why?
| | Computer Simulation | 1 | 2011 | 943 | 0.070 |
Why?
| | RNA, Neoplasm | 2 | 1998 | 88 | 0.070 |
Why?
| | Trans-Activators | 3 | 2000 | 388 | 0.070 |
Why?
| | Conduct Disorder | 1 | 2009 | 199 | 0.070 |
Why?
| | Orbital Neoplasms | 1 | 2006 | 21 | 0.070 |
Why?
| | Kinetics | 7 | 1997 | 1642 | 0.070 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2003 | 958 | 0.070 |
Why?
| | Chromosome Mapping | 2 | 1999 | 504 | 0.060 |
Why?
| | Guinea Pigs | 2 | 1997 | 157 | 0.060 |
Why?
| | Social Behavior | 1 | 2009 | 289 | 0.060 |
Why?
| | Luteinizing Hormone | 6 | 1997 | 179 | 0.060 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2008 | 207 | 0.060 |
Why?
| | Arachidonic Acid | 3 | 2003 | 115 | 0.060 |
Why?
| | Endometrial Neoplasms | 2 | 1998 | 164 | 0.060 |
Why?
| | Carcinoma, Transitional Cell | 1 | 2006 | 60 | 0.060 |
Why?
| | Pituitary Neoplasms | 3 | 2000 | 184 | 0.060 |
Why?
| | Middle Aged | 13 | 2019 | 31150 | 0.060 |
Why?
| | Benzodiazepines | 2 | 1997 | 136 | 0.060 |
Why?
| | Mice, Knockout | 2 | 2009 | 2871 | 0.060 |
Why?
| | Epithelium | 3 | 1996 | 311 | 0.060 |
Why?
| | Child | 13 | 2019 | 20882 | 0.060 |
Why?
| | Blotting, Southern | 2 | 1995 | 69 | 0.060 |
Why?
| | Protein-Tyrosine Kinases | 3 | 1997 | 432 | 0.060 |
Why?
| | Aging | 1 | 1995 | 1776 | 0.060 |
Why?
| | Receptors, Interleukin-6 | 2 | 1995 | 38 | 0.060 |
Why?
| | Proto-Oncogene Proteins | 2 | 2000 | 638 | 0.060 |
Why?
| | Structure-Activity Relationship | 3 | 1997 | 548 | 0.060 |
Why?
| | Genetic Predisposition to Disease | 2 | 2017 | 2282 | 0.060 |
Why?
| | Genes, nef | 1 | 2004 | 1 | 0.060 |
Why?
| | SAIDS Vaccines | 1 | 2004 | 4 | 0.060 |
Why?
| | Sex Factors | 1 | 2010 | 1968 | 0.060 |
Why?
| | Alzheimer Disease | 1 | 2010 | 519 | 0.060 |
Why?
| | Libraries | 1 | 2024 | 4 | 0.060 |
Why?
| | AIDS Vaccines | 1 | 2004 | 47 | 0.060 |
Why?
| | Books | 1 | 2024 | 3 | 0.060 |
Why?
| | DNA Primers | 2 | 1995 | 510 | 0.060 |
Why?
| | Mice, Transgenic | 1 | 2009 | 2119 | 0.060 |
Why?
| | Severity of Illness Index | 2 | 2009 | 2742 | 0.060 |
Why?
| | Asbestos | 1 | 2024 | 28 | 0.060 |
Why?
| | Hydrocarbons, Chlorinated | 1 | 2024 | 23 | 0.060 |
Why?
| | Fixation, Ocular | 1 | 2004 | 21 | 0.060 |
Why?
| | Iodine Radioisotopes | 2 | 1994 | 143 | 0.050 |
Why?
| | Radioimmunoassay | 4 | 1994 | 175 | 0.050 |
Why?
| | Postoperative Complications | 2 | 2018 | 2483 | 0.050 |
Why?
| | Glycoproteins | 2 | 1996 | 338 | 0.050 |
Why?
| | Norepinephrine | 2 | 2011 | 210 | 0.050 |
Why?
| | Quinidine | 2 | 2003 | 6 | 0.050 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2024 | 131 | 0.050 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 1 | 2004 | 83 | 0.050 |
Why?
| | Schizophrenia | 1 | 2008 | 431 | 0.050 |
Why?
| | Muscle Contraction | 3 | 1996 | 422 | 0.050 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2006 | 228 | 0.050 |
Why?
| | Electrophysiology | 5 | 2003 | 212 | 0.050 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 1998 | 821 | 0.050 |
Why?
| | Visual Fields | 2 | 2002 | 87 | 0.050 |
Why?
| | Odorants | 1 | 2024 | 150 | 0.050 |
Why?
| | Concept Formation | 1 | 2002 | 30 | 0.050 |
Why?
| | Serotonin Receptor Agonists | 2 | 2000 | 28 | 0.050 |
Why?
| | Pituitary Hormone-Releasing Hormones | 2 | 1994 | 10 | 0.050 |
Why?
| | Biguanides | 2 | 2000 | 12 | 0.050 |
Why?
| | Discrimination Learning | 2 | 2008 | 53 | 0.050 |
Why?
| | Vocabulary | 1 | 2002 | 46 | 0.050 |
Why?
| | Blotting, Western | 2 | 1995 | 1205 | 0.050 |
Why?
| | Adolescent Behavior | 1 | 2007 | 506 | 0.050 |
Why?
| | Inflammation | 1 | 1993 | 2736 | 0.050 |
Why?
| | Edema | 2 | 1993 | 124 | 0.050 |
Why?
| | Xenopus | 3 | 2001 | 86 | 0.050 |
Why?
| | Natriuretic Peptides | 1 | 2022 | 9 | 0.050 |
Why?
| | Treatment Outcome | 4 | 2018 | 10226 | 0.050 |
Why?
| | Rabbits | 3 | 1993 | 778 | 0.050 |
Why?
| | Mathematics | 1 | 2002 | 102 | 0.050 |
Why?
| | Calcium Compounds | 1 | 2001 | 4 | 0.050 |
Why?
| | Atrial Natriuretic Factor | 1 | 2022 | 56 | 0.050 |
Why?
| | Dopamine | 2 | 1996 | 289 | 0.050 |
Why?
| | Spatial Behavior | 1 | 2001 | 27 | 0.050 |
Why?
| | Transcription, Genetic | 4 | 1997 | 1418 | 0.050 |
Why?
| | Lactates | 1 | 2001 | 85 | 0.050 |
Why?
| | Hypocalcemia | 1 | 2001 | 28 | 0.050 |
Why?
| | Microsurgery | 1 | 2022 | 70 | 0.050 |
Why?
| | Prevalence | 3 | 2019 | 2564 | 0.050 |
Why?
| | Signal Transduction | 5 | 2001 | 4925 | 0.050 |
Why?
| | Sequence Alignment | 2 | 1999 | 332 | 0.040 |
Why?
| | Interferon-gamma | 1 | 2004 | 770 | 0.040 |
Why?
| | Neurons | 4 | 1997 | 1511 | 0.040 |
Why?
| | Tritium | 2 | 2000 | 75 | 0.040 |
Why?
| | Ion Channels | 1 | 2001 | 133 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 2 | 1999 | 131 | 0.040 |
Why?
| | Cell Membrane | 2 | 1994 | 732 | 0.040 |
Why?
| | Calcium Channels | 1 | 2001 | 164 | 0.040 |
Why?
| | Acute-Phase Proteins | 2 | 1997 | 67 | 0.040 |
Why?
| | Predictive Value of Tests | 3 | 2011 | 1952 | 0.040 |
Why?
| | Mesoderm | 1 | 2001 | 137 | 0.040 |
Why?
| | Radioligand Assay | 2 | 2000 | 48 | 0.040 |
Why?
| | Imagination | 1 | 2000 | 16 | 0.040 |
Why?
| | DNA | 3 | 1995 | 1400 | 0.040 |
Why?
| | Hormone Antagonists | 2 | 1997 | 32 | 0.040 |
Why?
| | Vasodilator Agents | 1 | 2022 | 326 | 0.040 |
Why?
| | Receptors, Eph Family | 1 | 1999 | 6 | 0.040 |
Why?
| | Tetraethylammonium | 1 | 1999 | 17 | 0.040 |
Why?
| | Evolution, Molecular | 2 | 2008 | 466 | 0.040 |
Why?
| | Chromosomes, Human, Pair 12 | 1 | 1999 | 21 | 0.040 |
Why?
| | DNA-Binding Proteins | 2 | 1997 | 1443 | 0.040 |
Why?
| | Phylogeny | 2 | 2003 | 852 | 0.040 |
Why?
| | 3,4-Dihydroxyphenylacetic Acid | 2 | 1996 | 19 | 0.040 |
Why?
| | Immunoblotting | 2 | 1997 | 305 | 0.040 |
Why?
| | Receptor, EphB4 | 1 | 1999 | 36 | 0.040 |
Why?
| | Infant | 5 | 2018 | 9025 | 0.040 |
Why?
| | GTP-Binding Proteins | 2 | 1999 | 157 | 0.040 |
Why?
| | Cytoskeleton | 1 | 2000 | 183 | 0.040 |
Why?
| | Ovariectomy | 2 | 1996 | 137 | 0.040 |
Why?
| | Arrhythmias, Cardiac | 1 | 2022 | 317 | 0.040 |
Why?
| | Cystadenocarcinoma, Papillary | 1 | 1999 | 5 | 0.040 |
Why?
| | Mice, Inbred C57BL | 1 | 2009 | 5440 | 0.040 |
Why?
| | Uterine Contraction | 1 | 1999 | 17 | 0.040 |
Why?
| | Fallopian Tube Neoplasms | 1 | 1999 | 15 | 0.040 |
Why?
| | Postpartum Period | 2 | 1999 | 332 | 0.040 |
Why?
| | Enoyl-CoA Hydratase | 1 | 1998 | 8 | 0.040 |
Why?
| | Eosinophils | 1 | 2001 | 324 | 0.040 |
Why?
| | Antigens, CD | 1 | 2001 | 489 | 0.040 |
Why?
| | Retrospective Studies | 4 | 2019 | 14519 | 0.040 |
Why?
| | Monocytes | 1 | 2001 | 551 | 0.040 |
Why?
| | Adenoma | 1 | 2000 | 214 | 0.040 |
Why?
| | Glycoprotein Hormones, alpha Subunit | 1 | 1998 | 22 | 0.040 |
Why?
| | Research | 1 | 2001 | 416 | 0.040 |
Why?
| | Fibroblast Growth Factor 9 | 1 | 1998 | 2 | 0.040 |
Why?
| | Binding Sites | 3 | 1999 | 1252 | 0.040 |
Why?
| | Spodoptera | 1 | 1998 | 37 | 0.040 |
Why?
| | Actins | 1 | 2000 | 411 | 0.040 |
Why?
| | Progestins | 1 | 1998 | 78 | 0.040 |
Why?
| | Muscle, Smooth | 2 | 1996 | 157 | 0.040 |
Why?
| | Baculoviridae | 1 | 1998 | 44 | 0.040 |
Why?
| | Antibody Specificity | 2 | 1997 | 184 | 0.040 |
Why?
| | Serotonin | 1 | 2000 | 321 | 0.040 |
Why?
| | Photic Stimulation | 2 | 2018 | 242 | 0.040 |
Why?
| | Membrane Proteins | 2 | 2001 | 1119 | 0.040 |
Why?
| | Carcinoma, Embryonal | 1 | 1997 | 2 | 0.040 |
Why?
| | Adipose Tissue, Brown | 1 | 1998 | 51 | 0.040 |
Why?
| | Species Specificity | 2 | 1996 | 575 | 0.040 |
Why?
| | Peptones | 1 | 1997 | 1 | 0.030 |
Why?
| | Medroxyprogesterone Acetate | 2 | 1998 | 35 | 0.030 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 1999 | 231 | 0.030 |
Why?
| | Gastric Acid | 1 | 1997 | 14 | 0.030 |
Why?
| | Drainage | 1 | 2018 | 165 | 0.030 |
Why?
| | Endothelin-1 | 1 | 1999 | 179 | 0.030 |
Why?
| | Lymphokines | 1 | 1997 | 127 | 0.030 |
Why?
| | Placental Lactogen | 1 | 1997 | 24 | 0.030 |
Why?
| | Pulmonary Veins | 1 | 2018 | 98 | 0.030 |
Why?
| | Neurosecretory Systems | 1 | 1997 | 31 | 0.030 |
Why?
| | Vaginal Neoplasms | 1 | 1996 | 12 | 0.030 |
Why?
| | Oligopeptides | 2 | 1999 | 257 | 0.030 |
Why?
| | Arcuate Nucleus of Hypothalamus | 1 | 1996 | 13 | 0.030 |
Why?
| | Tissue Polypeptide Antigen | 1 | 1996 | 2 | 0.030 |
Why?
| | Leiomyoma | 1 | 1997 | 74 | 0.030 |
Why?
| | Culture Media, Conditioned | 1 | 1997 | 110 | 0.030 |
Why?
| | Depression, Chemical | 1 | 1996 | 22 | 0.030 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 1996 | 56 | 0.030 |
Why?
| | Phenylurea Compounds | 1 | 1997 | 89 | 0.030 |
Why?
| | Uterine Neoplasms | 1 | 1997 | 102 | 0.030 |
Why?
| | Deoxyglucose | 1 | 1996 | 52 | 0.030 |
Why?
| | Oxytocin | 1 | 1996 | 48 | 0.030 |
Why?
| | Glucose Transporter Type 1 | 1 | 1996 | 49 | 0.030 |
Why?
| | Neoplasm Staging | 2 | 1998 | 1295 | 0.030 |
Why?
| | Cytoplasm | 1 | 1997 | 263 | 0.030 |
Why?
| | Molecular Structure | 1 | 1997 | 482 | 0.030 |
Why?
| | Transcriptional Activation | 1 | 1998 | 366 | 0.030 |
Why?
| | Trophoblasts | 1 | 1998 | 190 | 0.030 |
Why?
| | Carcinoma | 1 | 1998 | 217 | 0.030 |
Why?
| | Membrane Potentials | 4 | 2001 | 293 | 0.030 |
Why?
| | Potassium Channels, Inwardly Rectifying | 1 | 1996 | 36 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 1007 | 0.030 |
Why?
| | Coenzyme A Ligases | 1 | 1995 | 13 | 0.030 |
Why?
| | Immune Sera | 1 | 1995 | 86 | 0.030 |
Why?
| | Platelet Activating Factor | 1 | 1995 | 75 | 0.030 |
Why?
| | Submandibular Gland | 1 | 1995 | 19 | 0.030 |
Why?
| | Meta-Analysis as Topic | 1 | 2016 | 170 | 0.030 |
Why?
| | Piperazines | 2 | 2000 | 342 | 0.030 |
Why?
| | Receptors, Serotonin, 5-HT3 | 3 | 2000 | 14 | 0.030 |
Why?
| | Theophylline | 1 | 1995 | 68 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 1998 | 424 | 0.030 |
Why?
| | Protein Biosynthesis | 1 | 1997 | 406 | 0.030 |
Why?
| | Restriction Mapping | 1 | 1995 | 75 | 0.030 |
Why?
| | Genetic Heterogeneity | 1 | 1995 | 58 | 0.030 |
Why?
| | Azepines | 2 | 2010 | 89 | 0.030 |
Why?
| | Lipoprotein Lipase | 1 | 1995 | 59 | 0.030 |
Why?
| | Molecular Chaperones | 1 | 1996 | 182 | 0.030 |
Why?
| | Biological Transport | 1 | 1996 | 401 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 1997 | 539 | 0.030 |
Why?
| | Brain Chemistry | 1 | 1995 | 118 | 0.030 |
Why?
| | Mice, Inbred C3H | 1 | 1995 | 273 | 0.030 |
Why?
| | Gastric Mucosa | 1 | 1995 | 52 | 0.030 |
Why?
| | Thyrotropin-Releasing Hormone | 3 | 1997 | 12 | 0.030 |
Why?
| | Cystadenocarcinoma, Mucinous | 1 | 1994 | 14 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2016 | 307 | 0.030 |
Why?
| | Infertility, Male | 2 | 1985 | 60 | 0.030 |
Why?
| | Salivary Glands | 1 | 1994 | 29 | 0.030 |
Why?
| | Inhibins | 1 | 1994 | 45 | 0.030 |
Why?
| | Receptor, Cholecystokinin B | 1 | 1994 | 1 | 0.030 |
Why?
| | Vibration | 2 | 1988 | 69 | 0.030 |
Why?
| | Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1994 | 14 | 0.030 |
Why?
| | Gastrins | 1 | 1994 | 9 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 1997 | 833 | 0.030 |
Why?
| | Embolization, Therapeutic | 1 | 1996 | 207 | 0.030 |
Why?
| | Gestational Age | 1 | 1997 | 874 | 0.030 |
Why?
| | Haplorhini | 1 | 1994 | 50 | 0.030 |
Why?
| | Eye Infections, Viral | 1 | 1994 | 7 | 0.030 |
Why?
| | HTLV-I Infections | 1 | 1994 | 22 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 1996 | 457 | 0.030 |
Why?
| | RNA-Directed DNA Polymerase | 1 | 1994 | 34 | 0.030 |
Why?
| | Cystadenocarcinoma, Serous | 1 | 1994 | 69 | 0.030 |
Why?
| | Receptors, Fibroblast Growth Factor | 1 | 1994 | 65 | 0.030 |
Why?
| | Bronchodilator Agents | 1 | 1995 | 243 | 0.030 |
Why?
| | Pleurisy | 1 | 1993 | 5 | 0.030 |
Why?
| | Trachea | 1 | 1995 | 220 | 0.030 |
Why?
| | Vestibular Nuclei | 1 | 1973 | 7 | 0.030 |
Why?
| | Receptors, Estrogen | 1 | 1996 | 426 | 0.030 |
Why?
| | Posture | 2 | 1988 | 176 | 0.030 |
Why?
| | Ear, External | 1 | 1993 | 24 | 0.030 |
Why?
| | Hydrolysis | 1 | 1994 | 186 | 0.030 |
Why?
| | Survival Rate | 1 | 2018 | 1877 | 0.030 |
Why?
| | Lipoxygenase Inhibitors | 1 | 1993 | 38 | 0.030 |
Why?
| | Microbial Sensitivity Tests | 2 | 1991 | 352 | 0.030 |
Why?
| | Neuropeptides | 1 | 1993 | 71 | 0.030 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 1993 | 80 | 0.030 |
Why?
| | Cardiac Conduction System Disease | 1 | 2013 | 3 | 0.030 |
Why?
| | Neurotransmitter Uptake Inhibitors | 1 | 1993 | 3 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 1997 | 875 | 0.030 |
Why?
| | Reference Values | 2 | 1997 | 793 | 0.030 |
Why?
| | Child, Preschool | 6 | 2011 | 10518 | 0.030 |
Why?
| | Gestrinone | 1 | 1992 | 1 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2001 | 1928 | 0.030 |
Why?
| | Extracellular Space | 1 | 1993 | 120 | 0.030 |
Why?
| | Embryo, Mammalian | 1 | 1994 | 226 | 0.030 |
Why?
| | Down-Regulation | 1 | 1995 | 636 | 0.030 |
Why?
| | Cerebral Ventricles | 1 | 1993 | 50 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2018 | 781 | 0.030 |
Why?
| | Mice, Nude | 1 | 1994 | 683 | 0.030 |
Why?
| | Receptors, Cell Surface | 2 | 1985 | 380 | 0.030 |
Why?
| | Cyclic AMP | 1 | 1993 | 237 | 0.030 |
Why?
| | Mothers | 1 | 2019 | 728 | 0.030 |
Why?
| | Uveitis | 1 | 1994 | 127 | 0.030 |
Why?
| | Therapy, Computer-Assisted | 1 | 2013 | 60 | 0.020 |
Why?
| | Androgen-Insensitivity Syndrome | 2 | 1985 | 5 | 0.020 |
Why?
| | Myocardium | 1 | 1998 | 980 | 0.020 |
Why?
| | Energy Intake | 1 | 1995 | 461 | 0.020 |
Why?
| | Phospholipids | 1 | 1994 | 215 | 0.020 |
Why?
| | Mutation, Missense | 1 | 2014 | 317 | 0.020 |
Why?
| | Triglycerides | 1 | 1994 | 527 | 0.020 |
Why?
| | Isoflavones | 1 | 2012 | 25 | 0.020 |
Why?
| | Apoptosis | 2 | 2001 | 2503 | 0.020 |
Why?
| | Cell Division | 1 | 1993 | 797 | 0.020 |
Why?
| | Dihydrotestosterone | 2 | 1996 | 41 | 0.020 |
Why?
| | Weight Gain | 1 | 1995 | 510 | 0.020 |
Why?
| | Proteins | 1 | 1997 | 942 | 0.020 |
Why?
| | Social Control, Informal | 1 | 2011 | 22 | 0.020 |
Why?
| | Placebos | 1 | 2012 | 201 | 0.020 |
Why?
| | Death, Sudden, Cardiac | 1 | 2013 | 179 | 0.020 |
Why?
| | Genetics, Behavioral | 1 | 2011 | 40 | 0.020 |
Why?
| | Central Venous Pressure | 1 | 2011 | 14 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 1994 | 497 | 0.020 |
Why?
| | Peptides, Cyclic | 1 | 1993 | 256 | 0.020 |
Why?
| | Renin | 1 | 2011 | 32 | 0.020 |
Why?
| | Equipment Design | 1 | 2013 | 513 | 0.020 |
Why?
| | Arginine Vasopressin | 1 | 2011 | 42 | 0.020 |
Why?
| | Models, Genetic | 1 | 2014 | 594 | 0.020 |
Why?
| | Ovary | 1 | 1992 | 210 | 0.020 |
Why?
| | Cell Differentiation | 2 | 1997 | 1902 | 0.020 |
Why?
| | Pain | 1 | 1997 | 789 | 0.020 |
Why?
| | Testis | 3 | 1985 | 144 | 0.020 |
Why?
| | Sheep | 1 | 1993 | 837 | 0.020 |
Why?
| | Flurbiprofen | 1 | 2010 | 3 | 0.020 |
Why?
| | Stroop Test | 1 | 2010 | 26 | 0.020 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2010 | 27 | 0.020 |
Why?
| | Hyperprolactinemia | 1 | 1990 | 4 | 0.020 |
Why?
| | Prolactinoma | 1 | 1990 | 12 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2011 | 516 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2014 | 1502 | 0.020 |
Why?
| | Amyloid beta-Protein Precursor | 1 | 2010 | 62 | 0.020 |
Why?
| | Risk Factors | 2 | 2017 | 9763 | 0.020 |
Why?
| | Taurine | 1 | 2010 | 43 | 0.020 |
Why?
| | Dermatologic Agents | 2 | 2009 | 65 | 0.020 |
Why?
| | Ovarian Diseases | 1 | 1989 | 11 | 0.020 |
Why?
| | Gene Deletion | 2 | 2004 | 379 | 0.020 |
Why?
| | Hypothalamic Diseases | 1 | 1989 | 18 | 0.020 |
Why?
| | Pituitary Diseases | 1 | 1989 | 21 | 0.020 |
Why?
| | Sensitivity and Specificity | 2 | 2009 | 1838 | 0.020 |
Why?
| | HIV Infections | 1 | 2004 | 2720 | 0.020 |
Why?
| | Adenocarcinoma | 1 | 1996 | 898 | 0.020 |
Why?
| | Alanine | 1 | 2010 | 142 | 0.020 |
Why?
| | Environment | 1 | 2011 | 343 | 0.020 |
Why?
| | Electric Conductivity | 2 | 2002 | 94 | 0.020 |
Why?
| | Infertility, Female | 1 | 1990 | 104 | 0.020 |
Why?
| | Follow-Up Studies | 2 | 2010 | 4896 | 0.020 |
Why?
| | Neural Pathways | 1 | 2011 | 302 | 0.020 |
Why?
| | Color | 1 | 2009 | 71 | 0.020 |
Why?
| | Calibration | 1 | 2009 | 140 | 0.020 |
Why?
| | Photography | 1 | 2009 | 94 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2011 | 857 | 0.020 |
Why?
| | Attention Deficit and Disruptive Behavior Disorders | 1 | 2009 | 61 | 0.020 |
Why?
| | Protein Binding | 1 | 1994 | 2121 | 0.020 |
Why?
| | Regression Analysis | 1 | 2011 | 993 | 0.020 |
Why?
| | Cyclosporine | 1 | 2009 | 263 | 0.020 |
Why?
| | Oxygen Consumption | 1 | 2011 | 672 | 0.020 |
Why?
| | Kidney | 1 | 1995 | 1385 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2011 | 1201 | 0.020 |
Why?
| | Intelligence Tests | 1 | 2007 | 58 | 0.020 |
Why?
| | Schizophrenic Psychology | 1 | 2008 | 94 | 0.020 |
Why?
| | Dietary Supplements | 1 | 2012 | 534 | 0.020 |
Why?
| | Estrogens, Conjugated (USP) | 2 | 1978 | 46 | 0.020 |
Why?
| | Neurons, Afferent | 1 | 1988 | 99 | 0.020 |
Why?
| | Janus Kinase 1 | 2 | 1997 | 24 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2012 | 1876 | 0.020 |
Why?
| | Injections, Intravenous | 2 | 2004 | 201 | 0.020 |
Why?
| | Organ Size | 1 | 2008 | 447 | 0.020 |
Why?
| | Foot | 1 | 1988 | 93 | 0.020 |
Why?
| | Protein Kinase C | 2 | 1999 | 259 | 0.020 |
Why?
| | Bromocriptine | 2 | 1990 | 29 | 0.020 |
Why?
| | Antigens, Neoplasm | 1 | 1989 | 309 | 0.020 |
Why?
| | Pilot Projects | 1 | 2012 | 1587 | 0.020 |
Why?
| | Faculty | 1 | 2007 | 137 | 0.020 |
Why?
| | Enzyme Activation | 2 | 1999 | 811 | 0.020 |
Why?
| | Cystectomy | 1 | 2006 | 38 | 0.020 |
Why?
| | Preoperative Care | 2 | 1999 | 340 | 0.020 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2006 | 57 | 0.020 |
Why?
| | Menotropins | 1 | 1985 | 2 | 0.020 |
Why?
| | Aged | 5 | 2006 | 22099 | 0.020 |
Why?
| | Thalamic Nuclei | 2 | 1984 | 10 | 0.020 |
Why?
| | Progesterone | 3 | 1996 | 245 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2006 | 300 | 0.020 |
Why?
| | Molecular Weight | 2 | 1996 | 332 | 0.010 |
Why?
| | Alleles | 1 | 2008 | 845 | 0.010 |
Why?
| | Models, Biological | 2 | 2003 | 1722 | 0.010 |
Why?
| | Neutralization Tests | 1 | 2004 | 73 | 0.010 |
Why?
| | Behavior, Animal | 1 | 2008 | 508 | 0.010 |
Why?
| | HIV Antibodies | 1 | 2004 | 57 | 0.010 |
Why?
| | Cats | 4 | 1984 | 208 | 0.010 |
Why?
| | Vaccines, Synthetic | 1 | 2004 | 126 | 0.010 |
Why?
| | Comorbidity | 1 | 2009 | 1547 | 0.010 |
Why?
| | Simian Immunodeficiency Virus | 1 | 2004 | 85 | 0.010 |
Why?
| | Macaca mulatta | 1 | 2004 | 149 | 0.010 |
Why?
| | CD4 Lymphocyte Count | 1 | 2004 | 266 | 0.010 |
Why?
| | Vaccines, Attenuated | 1 | 2004 | 125 | 0.010 |
Why?
| | Phosphorylation | 2 | 1999 | 1713 | 0.010 |
Why?
| | Propafenone | 1 | 2003 | 2 | 0.010 |
Why?
| | Quinine | 1 | 2003 | 16 | 0.010 |
Why?
| | Barium | 1 | 2003 | 28 | 0.010 |
Why?
| | Ethanolamines | 1 | 2003 | 17 | 0.010 |
Why?
| | Recombination, Genetic | 1 | 2004 | 190 | 0.010 |
Why?
| | Glyburide | 1 | 2003 | 35 | 0.010 |
Why?
| | Lidocaine | 1 | 2003 | 41 | 0.010 |
Why?
| | HIV | 1 | 2004 | 226 | 0.010 |
Why?
| | Biopsy | 1 | 2006 | 1097 | 0.010 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2003 | 111 | 0.010 |
Why?
| | Docosahexaenoic Acids | 1 | 2003 | 83 | 0.010 |
Why?
| | Viral Load | 1 | 2004 | 448 | 0.010 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2003 | 160 | 0.010 |
Why?
| | Lymphocytes | 1 | 2004 | 377 | 0.010 |
Why?
| | Delayed Rectifier Potassium Channels | 1 | 2002 | 9 | 0.010 |
Why?
| | Protein Kinase Inhibitors | 2 | 1999 | 891 | 0.010 |
Why?
| | Shab Potassium Channels | 1 | 2002 | 18 | 0.010 |
Why?
| | Prognosis | 1 | 2010 | 3794 | 0.010 |
Why?
| | NAD+ Nucleosidase | 1 | 2001 | 3 | 0.010 |
Why?
| | ADP-ribosyl Cyclase | 1 | 2001 | 5 | 0.010 |
Why?
| | Adenosine Diphosphate Ribose | 1 | 2001 | 7 | 0.010 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2003 | 119 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2003 | 544 | 0.010 |
Why?
| | ADP-ribosyl Cyclase 1 | 1 | 2001 | 37 | 0.010 |
Why?
| | Risk Assessment | 1 | 2011 | 3240 | 0.010 |
Why?
| | Fetal Proteins | 1 | 2001 | 16 | 0.010 |
Why?
| | Antigens, Differentiation | 1 | 2001 | 81 | 0.010 |
Why?
| | Jurkat Cells | 1 | 2001 | 134 | 0.010 |
Why?
| | Perciformes | 1 | 2001 | 17 | 0.010 |
Why?
| | Aptitude Tests | 1 | 2001 | 4 | 0.010 |
Why?
| | Lung | 1 | 2014 | 3931 | 0.010 |
Why?
| | Muscle Spindles | 1 | 1981 | 6 | 0.010 |
Why?
| | Clomiphene | 1 | 1981 | 15 | 0.010 |
Why?
| | Twin Studies as Topic | 1 | 2001 | 19 | 0.010 |
Why?
| | NAD | 1 | 2001 | 75 | 0.010 |
Why?
| | Amenorrhea | 1 | 1981 | 27 | 0.010 |
Why?
| | Protein Subunits | 1 | 2002 | 235 | 0.010 |
Why?
| | Ovulation Induction | 1 | 1981 | 55 | 0.010 |
Why?
| | Phalloidine | 1 | 2000 | 2 | 0.010 |
Why?
| | Cytochalasin B | 1 | 2000 | 17 | 0.010 |
Why?
| | RNA, Viral | 1 | 2004 | 619 | 0.010 |
Why?
| | Stimulation, Chemical | 1 | 2000 | 63 | 0.010 |
Why?
| | Kruppel-Like Factor 6 | 1 | 2000 | 1 | 0.010 |
Why?
| | Tubocurarine | 1 | 2000 | 4 | 0.010 |
Why?
| | Spinal Cord | 1 | 2003 | 356 | 0.010 |
Why?
| | TRPM Cation Channels | 1 | 2001 | 77 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2003 | 840 | 0.010 |
Why?
| | T-Box Domain Proteins | 1 | 2001 | 96 | 0.010 |
Why?
| | Ondansetron | 1 | 2000 | 15 | 0.010 |
Why?
| | Skin | 1 | 1985 | 725 | 0.010 |
Why?
| | Serotonin Antagonists | 1 | 2000 | 31 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2008 | 2073 | 0.010 |
Why?
| | Antibodies, Viral | 1 | 2004 | 601 | 0.010 |
Why?
| | Ferrets | 1 | 2000 | 25 | 0.010 |
Why?
| | Fibroblasts | 1 | 1985 | 948 | 0.010 |
Why?
| | Fatty Acids | 1 | 2003 | 427 | 0.010 |
Why?
| | Exocytosis | 1 | 2000 | 88 | 0.010 |
Why?
| | Cerebellar Nuclei | 1 | 1980 | 9 | 0.010 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2000 | 67 | 0.010 |
Why?
| | Actin Cytoskeleton | 1 | 2000 | 104 | 0.010 |
Why?
| | Biomarkers | 1 | 2011 | 3973 | 0.010 |
Why?
| | Clinical Protocols | 1 | 2001 | 255 | 0.010 |
Why?
| | Microscopy, Confocal | 1 | 2000 | 310 | 0.010 |
Why?
| | Ritodrine | 1 | 1999 | 1 | 0.010 |
Why?
| | Son of Sevenless Proteins | 1 | 1999 | 4 | 0.010 |
Why?
| | Virulence Factors, Bordetella | 1 | 1999 | 19 | 0.010 |
Why?
| | Pertussis Toxin | 1 | 1999 | 26 | 0.010 |
Why?
| | Imidazoles | 1 | 2000 | 234 | 0.010 |
Why?
| | Endothelin Receptor Antagonists | 1 | 1999 | 62 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 2001 | 480 | 0.010 |
Why?
| | Receptor, Endothelin A | 1 | 1999 | 63 | 0.010 |
Why?
| | Membrane Glycoproteins | 1 | 2001 | 474 | 0.010 |
Why?
| | Ion Transport | 1 | 1999 | 62 | 0.010 |
Why?
| | Cations | 1 | 1999 | 80 | 0.010 |
Why?
| | Permeability | 1 | 1999 | 157 | 0.010 |
Why?
| | Zebrafish Proteins | 1 | 2001 | 265 | 0.010 |
Why?
| | Prospective Studies | 1 | 2010 | 7131 | 0.010 |
Why?
| | Postural Balance | 1 | 1981 | 200 | 0.010 |
Why?
| | Hemolytic Plaque Technique | 1 | 1997 | 28 | 0.010 |
Why?
| | Secretory Rate | 1 | 1997 | 18 | 0.010 |
Why?
| | Oocytes | 1 | 1999 | 176 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-raf | 1 | 1997 | 45 | 0.010 |
Why?
| | Gadolinium DTPA | 1 | 1998 | 51 | 0.010 |
Why?
| | MAP Kinase Kinase 2 | 1 | 1997 | 29 | 0.010 |
Why?
| | Cervix Uteri | 1 | 1998 | 50 | 0.010 |
Why?
| | Endometrium | 1 | 1998 | 61 | 0.010 |
Why?
| | Leukemia Inhibitory Factor | 1 | 1997 | 6 | 0.010 |
Why?
| | Myometrium | 1 | 1998 | 37 | 0.010 |
Why?
| | MAP Kinase Kinase 1 | 1 | 1997 | 76 | 0.010 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 1998 | 158 | 0.010 |
Why?
| | Devazepide | 1 | 1997 | 1 | 0.010 |
Why?
| | Pentagastrin | 1 | 1997 | 3 | 0.010 |
Why?
| | Famotidine | 1 | 1997 | 2 | 0.010 |
Why?
| | Colorado | 1 | 2007 | 4420 | 0.010 |
Why?
| | Atropine | 1 | 1997 | 24 | 0.010 |
Why?
| | Benzodiazepinones | 1 | 1997 | 17 | 0.010 |
Why?
| | Indoles | 1 | 2000 | 387 | 0.010 |
Why?
| | Pituitary Gland, Posterior | 1 | 1997 | 2 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 2000 | 779 | 0.010 |
Why?
| | Methacholine Chloride | 1 | 1997 | 51 | 0.010 |
Why?
| | Genes, ras | 1 | 1997 | 97 | 0.010 |
Why?
| | Janus Kinase 2 | 1 | 1997 | 32 | 0.010 |
Why?
| | Colchicine | 1 | 1997 | 24 | 0.010 |
Why?
| | STAT1 Transcription Factor | 1 | 1997 | 70 | 0.010 |
Why?
| | Muscarinic Antagonists | 1 | 1997 | 27 | 0.010 |
Why?
| | Injections, Intraventricular | 1 | 1997 | 55 | 0.010 |
Why?
| | Luciferases | 1 | 1997 | 148 | 0.010 |
Why?
| | Histamine | 1 | 1997 | 65 | 0.010 |
Why?
| | Chemokine CXCL1 | 1 | 1997 | 73 | 0.010 |
Why?
| | Histamine H2 Antagonists | 1 | 1997 | 29 | 0.010 |
Why?
| | Clusterin | 1 | 1996 | 11 | 0.010 |
Why?
| | Gene Transfer Techniques | 1 | 1998 | 163 | 0.010 |
Why?
| | Tyrosine | 1 | 1997 | 223 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2004 | 2391 | 0.010 |
Why?
| | Psychometrics | 1 | 2001 | 691 | 0.010 |
Why?
| | Stomach | 1 | 1997 | 109 | 0.010 |
Why?
| | Formaldehyde | 1 | 1997 | 60 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2006 | 2535 | 0.010 |
Why?
| | Stereoisomerism | 1 | 1996 | 99 | 0.010 |
Why?
| | Seizures | 1 | 1980 | 402 | 0.010 |
Why?
| | G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 1996 | 8 | 0.010 |
Why?
| | Leptin | 1 | 1997 | 219 | 0.010 |
Why?
| | ROC Curve | 1 | 1998 | 503 | 0.010 |
Why?
| | Neoplasm Invasiveness | 1 | 1998 | 485 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 1999 | 643 | 0.010 |
Why?
| | Dogs | 1 | 1997 | 381 | 0.010 |
Why?
| | Vaccination | 1 | 2004 | 1348 | 0.010 |
Why?
| | Chorionic Gonadotropin | 1 | 1976 | 80 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 1996 | 426 | 0.010 |
Why?
| | Conjugation, Genetic | 1 | 1975 | 5 | 0.010 |
Why?
| | Mannose | 1 | 1975 | 25 | 0.010 |
Why?
| | Electric Stimulation | 2 | 1973 | 269 | 0.010 |
Why?
| | Glucosamine | 1 | 1975 | 13 | 0.010 |
Why?
| | Receptors, FSH | 2 | 1985 | 9 | 0.010 |
Why?
| | STAT3 Transcription Factor | 1 | 1997 | 195 | 0.010 |
Why?
| | Ciliophora | 1 | 1975 | 15 | 0.010 |
Why?
| | Chlorides | 1 | 1996 | 139 | 0.010 |
Why?
| | Contrast Media | 1 | 1998 | 393 | 0.010 |
Why?
| | Dendrites | 1 | 1996 | 100 | 0.010 |
Why?
| | gamma-Aminobutyric Acid | 1 | 1996 | 169 | 0.010 |
Why?
| | Activins | 1 | 1994 | 27 | 0.010 |
Why?
| | Growth Hormone-Releasing Hormone | 1 | 1994 | 24 | 0.010 |
Why?
| | Polycystic Ovary Syndrome | 1 | 1977 | 163 | 0.010 |
Why?
| | Cross-Cultural Comparison | 1 | 1995 | 82 | 0.010 |
Why?
| | Dexamethasone | 1 | 1996 | 346 | 0.010 |
Why?
| | Axons | 1 | 1996 | 191 | 0.010 |
Why?
| | Eating | 1 | 1997 | 369 | 0.010 |
Why?
| | Corticotropin-Releasing Hormone | 1 | 1994 | 61 | 0.010 |
Why?
| | Adenosine | 1 | 1996 | 227 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2004 | 4063 | 0.010 |
Why?
| | HTLV-I Antibodies | 1 | 1994 | 5 | 0.010 |
Why?
| | Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 1993 | 4 | 0.010 |
Why?
| | Vasoactive Intestinal Peptide | 1 | 1993 | 12 | 0.010 |
Why?
| | Cytosol | 1 | 1994 | 218 | 0.010 |
Why?
| | Human T-lymphotropic virus 1 | 1 | 1994 | 28 | 0.010 |
Why?
| | Estrogens | 1 | 1996 | 347 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 1996 | 1245 | 0.010 |
Why?
| | Muscles | 2 | 1988 | 322 | 0.010 |
Why?
| | Natural Language Processing | 1 | 1995 | 94 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 1998 | 1207 | 0.010 |
Why?
| | Seroepidemiologic Studies | 1 | 1994 | 156 | 0.010 |
Why?
| | Benztropine | 1 | 1993 | 2 | 0.010 |
Why?
| | Organ Specificity | 1 | 1994 | 296 | 0.010 |
Why?
| | Infusions, Parenteral | 1 | 1993 | 38 | 0.010 |
Why?
| | Dopamine Antagonists | 1 | 1993 | 23 | 0.010 |
Why?
| | Gonadotropins, Equine | 1 | 1992 | 3 | 0.010 |
Why?
| | 3-Hydroxysteroid Dehydrogenases | 1 | 1992 | 8 | 0.010 |
Why?
| | Hypophysectomy | 1 | 1992 | 15 | 0.010 |
Why?
| | Steroid 17-alpha-Hydroxylase | 1 | 1992 | 4 | 0.010 |
Why?
| | Aldehyde-Lyases | 1 | 1992 | 3 | 0.010 |
Why?
| | 17-Hydroxysteroid Dehydrogenases | 1 | 1992 | 5 | 0.010 |
Why?
| | Aromatase | 1 | 1992 | 31 | 0.010 |
Why?
| | Visual Cortex | 1 | 1973 | 68 | 0.010 |
Why?
| | Electromyography | 2 | 1988 | 381 | 0.010 |
Why?
| | Synapses | 1 | 1996 | 400 | 0.010 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 1992 | 151 | 0.010 |
Why?
| | Oligodendroglia | 1 | 1994 | 166 | 0.010 |
Why?
| | Cortical Spreading Depression | 1 | 1971 | 9 | 0.010 |
Why?
| | Amino Acids | 1 | 1975 | 485 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 1997 | 2406 | 0.010 |
Why?
| | Androgens | 1 | 1992 | 177 | 0.010 |
Why?
| | Neuroglia | 1 | 1971 | 168 | 0.010 |
Why?
| | Epithelial Cells | 1 | 1996 | 1065 | 0.010 |
Why?
| | Monitoring, Immunologic | 1 | 1989 | 23 | 0.010 |
Why?
| | Carcinoembryonic Antigen | 1 | 1989 | 41 | 0.010 |
Why?
| | Dermoid Cyst | 1 | 1989 | 15 | 0.010 |
Why?
| | Visual Pathways | 2 | 1984 | 50 | 0.000 |
Why?
| | Mutation | 1 | 1999 | 3717 | 0.000 |
Why?
| | Testosterone | 2 | 1984 | 372 | 0.000 |
Why?
| | Incidence | 1 | 1994 | 2644 | 0.000 |
Why?
| | RNA | 1 | 1993 | 883 | 0.000 |
Why?
| | Methoxyflurane | 1 | 1966 | 2 | 0.000 |
Why?
| | Acid-Base Equilibrium | 1 | 1966 | 27 | 0.000 |
Why?
| | Gonadal Dysgenesis | 1 | 1985 | 8 | 0.000 |
Why?
| | Turner Syndrome | 1 | 1985 | 52 | 0.000 |
Why?
| | Hypothermia, Induced | 1 | 1966 | 76 | 0.000 |
Why?
| | Ischemia | 1 | 1988 | 406 | 0.000 |
Why?
| | Spermatogenesis | 1 | 1984 | 62 | 0.000 |
Why?
| | Obesity | 1 | 1997 | 2882 | 0.000 |
Why?
| | Evoked Potentials, Visual | 1 | 1984 | 35 | 0.000 |
Why?
| | Superior Colliculi | 1 | 1984 | 37 | 0.000 |
Why?
| | Half-Life | 1 | 1983 | 162 | 0.000 |
Why?
| | Aged, 80 and over | 1 | 1994 | 7084 | 0.000 |
Why?
| | Reflex, Stretch | 1 | 1981 | 10 | 0.000 |
Why?
| | Mechanoreceptors | 1 | 1981 | 16 | 0.000 |
Why?
| | Achilles Tendon | 1 | 1981 | 31 | 0.000 |
Why?
| | Penicillin G | 1 | 1980 | 7 | 0.000 |
Why?
| | Nerve Block | 1 | 1981 | 65 | 0.000 |
Why?
| | Brain Mapping | 1 | 1984 | 574 | 0.000 |
Why?
| | Cerebellar Cortex | 1 | 1980 | 21 | 0.000 |
Why?
| | Purkinje Cells | 1 | 1980 | 71 | 0.000 |
Why?
| | Leg | 1 | 1981 | 238 | 0.000 |
Why?
| | Drug Therapy, Combination | 1 | 1981 | 1040 | 0.000 |
Why?
| | Antibiotics, Antitubercular | 1 | 1956 | 37 | 0.000 |
Why?
| | Neoplasms, Experimental | 1 | 1956 | 171 | 0.000 |
Why?
| | Geniculate Bodies | 1 | 1973 | 15 | 0.000 |
Why?
| | Potassium | 1 | 1971 | 143 | 0.000 |
Why?
| | Anti-Bacterial Agents | 1 | 1956 | 1717 | 0.000 |
Why?
| | Chromatography, Gas | 1 | 1966 | 32 | 0.000 |
Why?
| | Plethysmography | 1 | 1966 | 107 | 0.000 |
Why?
| | Antineoplastic Agents | 1 | 1956 | 2061 | 0.000 |
Why?
| | Brain Diseases | 1 | 1966 | 137 | 0.000 |
Why?
| | Cardiovascular Diseases | 1 | 1966 | 2004 | 0.000 |
Why?
|
|
Miyake's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|